Vera Bradley, Inc.: Form 10-Q for the period ended Nov 1, 2025
Filed with the SEC on Dec 11, 2025 and accepted by EDGAR at Dec 11, 2025, 21:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-11-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-08-03 to 2025-11-01 | $62.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-02-02 to 2025-11-01 | $184.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-08-03 to 2025-11-01 | $36.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2025-02-02 to 2025-11-01 | $100.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-08-03 to 2025-11-01 | $26.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-02-02 to 2025-11-01 | $84.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2025-08-03 to 2025-11-01 | $38.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2025-02-02 to 2025-11-01 | $119.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-08-03 to 2025-11-01 | −$12.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-02-02 to 2025-11-01 | −$34.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-08-03 to 2025-11-01 | $56.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-02-02 to 2025-11-01 | $446.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-08-03 to 2025-11-01 | −$12.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-02-02 to 2025-11-01 | −$50.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-08-03 to 2025-11-01 | −$0.44 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-02-02 to 2025-11-01 | −$1.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-08-03 to 2025-11-01 | −$0.44 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-02-02 to 2025-11-01 | −$1.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-08-03 to 2025-11-01 | 27,937,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-02-02 to 2025-11-01 | 27,984,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-02-02 to 2025-11-01 | −$27.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-02-02 to 2025-11-01 | $3.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2025-02-02 to 2025-11-01 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-11-01 | $10.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-11-01 | $122.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-11-01 | $243.7m | us-gaap:Assets |
| Current liabilities | At period end2025-11-01 | $48.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-11-01 | $115.6m | us-gaap:Liabilities |
| Long-term debt | At period end2025-11-01 | $10.0m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2025-11-01 | $128.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-056518. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.